Sfoglia per Autore
DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: Results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study
2001-01-01 Russo A.; Bazan V.; Migliavacca M.; Tubiolo C.; Macaluso M.; Zanna I.; Corsale S.; Latteri F.; Valerio M.R.; Pantuso G.; Morello V.; Dardanoni G.; Latteri M.A.; Colucci G.; Tomasino R.M.; Gebbia N.
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study
2002-01-01 Bazan V.; Migliavacca M.; Zanna I.; Tubiolo C.; Corsale S.; Calo V.; Amato A.; Cammareri P.; Latteri F.; Grassi N.; Fulfaro F.; Porcasi R.; Morello V.; Nuara R.B.; Dardanoni G.; Salerno S.; Valerio M.R.; Dusonchet L.; Gerbino A.; Gebbia N.; Tomasino R.M.; Russo A.
p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: A prospective study with a five-year follow-up
2002-01-01 Russo, A; Migliavacca, M; Zanna, I; Valerio, MR; Latteri, MA; Grassi, N; Pantuso, G; Salerno, S; Dardanoni, G; Albanese, I; La Farina, M; Tomasino, RM; Gebbia, N; Bazan, V
Topotecan compared with no terapy and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study
2004-01-01 DE PLACIDO S; SCAMBIA G; DI VAGNO G; NAGLIERI E; LOMBARDI A V; BIAMONTE R; MARINACCIO M; CARTENI G; MANZIONE L; FEBBRARO A; DE MATTEIS A; VALERIO MR; DANESE S; PERRONE F; LAURIA R; DE LAURENTIS M; GREGGI S; GALLO C; PIGNATA S
GRUPPO ONCOLOGICO ITALIA MERIDIONALE. NOVEL ASSOCIATION WITH GEMCITABINE AND DOCETAXEL AS SALVAGE CHEMOTHERAPY IN METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH ANTHRACYCLINES: RESULT OF A NULTICENTER PHASE II STUDY
2004-01-01 BRANDI M; VICI P; LOPEZ M; VALERIO MR; GIOTTA F; GEBBIA N; SCHITULLI F; COLUCCI G
TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome
2004-01-01 MIGLIAVACCA M; OTTINI L; BAZAN V; AGNESE V; CORSALE S; MACALUSO M; LUPI R; DARDANONI G; VALERIO MR; PANTUSO G; DI FEDE G; TOMASINO RM; GEBBIA N; MARIANI-COSTANTINI R; RUSSO A
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study.
2005-01-01 BAZAN, V; AGNESE, V; CORSALE, S; CALO', V; VALERIO, MR; LATTERI, M; VIENI, S; GRASSI, N; CICERO, G; DARDANONI, G; TOMASINO, RM; COLUCCI, G; GEBBIA, N; RUSSO, A; Vieni, S.
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.
2006-01-01 GARGANO G; AGNESE V; CALO V; CORSALE S; AUGELLO C; BRUNO L; LA PAGLIA L; GULLO A; OTTINI L; RUSSO A; FULFARO F; RINALDI G; CROSTA A; CICERO G; MAJORANA; O; PALMERI L; CIPOLLA C; AGRUSA A; GULOTTA G; MORELLO V; DI FEDE G; ADAMO V; COLUCCI G; TOMASINO RM; VALERIO MR; BAZAN V; RUSSO A
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study.
2006-01-01 PIGNATA, S; DE PLACIDO, S; BIAMONTE, R; SCAMBIA, G; DI VAGNO, G; COLUCCI, G; FEBBRARO, A; MARINACCIO, M; LOMBARDI, AV; MANZIONE, L; CARTENI, G; NARDI, M; DANESE, S; VALERIO, MR; DE MATTEIS, A; MASSIDDA, B; GASPARINI, G; DI MAIO, M; PISANO, C; PERRONE, F
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers
2006-01-01 VERDERAME, F; RUSSO, A; DI LEO, R; BADALAMENTI, G; SANTANGELO, D; CICERO, G; VALERIO, MR; GULOTTA, G; TOMASELLO, G; GEBBIA, N; FULFARO, F
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study
2006-01-01 AGNESE V; CORSALE S; CALO V; AUGELLO C; BRUNO L; CALCARA D; CROSTA A; RODOLICO V; RINALDI G; CICERO G; LATTERI F; AGRUSA A; MORELLO V; ADAMO V; ALTAVILLA G; DI FEDE G; FIORENTINO E; GRASSI N; LATTERI M; VALERIO MR; TOMASINO RM; COLUCCI G; BAZAN V; RUSSO A
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma
2006-01-01 VALERIO MR; TAGLIAFERRI P; RASPAGLIESI F; FULFARO F; BADALAMENTI G; ARCARA; C; CICERO G; RUSSO A; VENUTA S; GUARNERI G; GEBBIA N
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.
2006-01-01 BAZAN V; BRUNO L; AUGELLO C; AGNESE V; CALO V; CORSALE S; GARGANO G; TERRASI; M; SCHIRO V; DI FEDE G; ADAMO V; INTRIVICI C; CROSTA A; RINALDI G; LATTERI F; DARDANONI G; GRASSI N; VALERIO MR; COLUCCI G; MACALUSO M; RUSSO A
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study
2006-01-01 AUGELLO C; BRUNO L; BAZAN V; CALO V; AGNESE V; CORSALE S; CASCIO S; GARGANO; G; TERRASI M; BARBERA F; FRICANO S; ADAMO B; VALERIO MR; COLUCCI G; SUMARCZ E; RUSSO A
Clinical presentation and treatment of gastrointestinal stromal tumors.
2006-01-01 CIPOLLA C; FULFARO F; SANDONATO L; FRICANO S; PANTUSO G; GRASSI N; VIENI, S; VALERIO MR; LO DICO R; GEBBIA N; LATTERI M
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer.
2006-01-01 CALO V; AGNESE V; GARGANO G; CORSALE S; GREGORIO V; CASCIO S; CAMMARERI P; BRUNO L; AUGELLO C; GULLO A; SISTO PS; BADALAMENTI G; VALERIO MR; NAPOLI L; GEBBIA N; BAZAN V; RUSSO A
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study.
2007-01-01 Ferrandina, G; Ludovisi, M; De Vincenzo, R; Salutari, V; Lorusso, D; Colangelo, M; Prantera, T; Valerio, MR; Scambia, G
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan
2007-01-01 VINCENZI B; SANTINI D; RUSSO A; GAVASCI M; BATTISTONI F; DICUONZO G; ROCCI L; VALERIO MR; GEBBIA N; TONINI G
Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study).
2007-01-01 ADAMO V; FRANCHINA T; ADAMO B; FERRARO G; ROSSELLO R; MAUGERI SACCA M; SCIBILIA C; VALERIO MR; RUSSO A
Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study
2007-01-01 Giotta, F; Lorusso, V; Maiello, E; Filippelli, G; Valerio, MR; Caruso, M; Verderame, F; Latorre, A; Colucci, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile